Jean-Christophe Lone

Jean-Christophe Lone

Auto-generated profile, based on publicly available information

Jean-Christophe Lone

GIMM, Gulbenkian Institute for Molecular Medicine and Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2021 in Royal Society Open Science
Verified
Journal Article
Open access
NRNancy Rebout
Nancy Rebout
JLJean-Christophe Lone
Jean-Christophe Lone
AMArianna De Marco
Arianna De Marco
RCRoberto Cozzolino
Roberto Cozzolino
ALAlban Lemasson
Alban Lemasson
BTBernard THIERRY
Bernard THIERRY
While there is no consensus about the definition of complexity, it is widely accepted that the ability to produce uncertainty is the most prominent characteristic of complex systems. We introduce new metrics that purport to quantify the complexity of living organisms and social organizations based on their levels of uncertainty. We consider three major dimensions regarding complexity: diversity based on the number of system elements and the number of categories of these elements; flexibility which bears upon variations in the elements; and combinability which refers to the patterns of connection between elements. These three dimensions are quantified using Shannon's uncertainty formula, and they can be integrated to provide a tripartite complexity index. We provide a calculation example that illustrates the use of these indices for comparing the complexity of different social systems. These indices distinguish themselves by a theoretical basis grounded on the amount of uncertainty, and the requirement that several aspects of the systems be accounted for to compare their degree of complexity. We expect that these new complexity indices will encourage research programmes aiming to compare the complexity levels of systems belonging to different realms.

16 July 2026 in Science
Verified
Journal Article
Closed access
RMRaphaël Mattiuz
Raphaël Mattiuz
JBJesse Boumelha
Jesse Boumelha
EAEmmanouil Aerakis
Emmanouil Aerakis
JBJessica Le Berichel
Jessica Le Berichel
PHPauline Hamon
Pauline Hamon
MMMiriam Merad
Miriam Merad
Tertiary lymphoid structures (TLSs) are associated with immunotherapy response, yet the mechanisms controlling their formation and maintenance remain unclear. Using spatial transcriptomics and multiplex imaging across human tumors, we found that CCR7 + mature dendritic cells (DCs) accumulate in TLSs. In a mouse non–small cell lung cancer model that forms mature TLSs, we show that early TLS development requires interferon-γ (IFN-γ)–driven type 1 conventional dendritic cell (cDC1) maturation, migration to tumor-draining lymph nodes (tdLNs), and T cell recruitment. As tumors progress, TLSs persist independently of tdLN T cell egress, coinciding with cDC1 accumulation within intratumoral CCL19 stromal hubs. There, cDC1–major histocompatibility complex class 1 (MHC-I) and –MHC-II concomitant antigen presentation, along with CD40 signaling, sustain TLS, T follicular helper (T FH ) cell pool, germinal centers, and tumor-specific immunoglobulin G (IgG). These findings highlight local mature cDC1s as key TLS orchestrators and potential targets to enhance antitumor TLS function.

29 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
DMDebanjan Mukherjee
Debanjan Mukherjee
ÂCÂngelo Ferreira Chora
Ângelo Ferreira Chora
JLJean-Christophe Lone
Jean-Christophe Lone
RRRicardo S. Ramiro
Ricardo S. Ramiro
BBBirte Blankenhaus
Birte Blankenhaus
MMMaria M. Mota
Maria M. Mota
Severe malaria can manifest itself with a variety of well-recognized clinical phenotypes that are highly predictive of death – severe anaemia, coma (cerebral malaria), multiple organ failure, and respiratory distress. The reasons why an infected individual develops one pathology rather than another remain poorly understood. Here we use distinct rodent models of infection to show that the host microbiota is a contributing factor for the development of respiratory distress syndrome and host mortality in the context of malaria infections (malaria-associated acute respiratory distress syndrome, MA-ARDS). We show that parasite sequestration in the lung results in sustained immune activation. Subsequent production of the anti-inflammatory cytokine IL-10 by T cells compromises microbial control, leading to severe lung disease. Notably, bacterial clearance with linezolid, an antibiotic commonly used in the clinical setting to control lung-associated bacterial infections, prevents MA-ARDS-associated lethality. Thus, we propose that the host’s anti-inflammatory response to limit tissue damage can result in loss of microbial control, which promotes MA-ARDS. This must be considered when intervening against life-threatening respiratory complications.

6 May 2022 in Behavioral Ecology and Sociobiology
Verified
Journal Article
Closed access
PDF file
NRNancy Rebout
Nancy Rebout
AMArianna De Marco
Arianna De Marco
ASAndrea Sanna
Andrea Sanna
JMJérôme Micheletta
Jérôme Micheletta
JLJean-Christophe Lone
Jean-Christophe Lone
ALAlban Lemasson
Alban Lemasson

26 November 2024 in European Journal of Immunology
Verified
Journal Article
Closed access
LDLisa Dratva
Lisa Dratva
ADAlice Driessen
Alice Driessen
IFIgor Filippov
Igor Filippov
SGStéphane Guillaume
Stéphane Guillaume
LHLisa Hoenicke
Lisa Hoenicke
JLJean‐Christophe Lone
Jean‐Christophe Lone

30 June 2026 in bioRxiv
Verified
Preprint
Open access
SRSonia Trikha Rastogi
Sonia Trikha Rastogi
MMMiguel Mesquita
Miguel Mesquita
DFDiogo Martins Fonseca
Diogo Martins Fonseca
SSSara Salazar
Sara Salazar
SCSilvia Cardoso
Silvia Cardoso
MSMiguel P. Soares
Miguel P. Soares
Disease tolerance limits infectious disease severity through tissue damage control mechanisms that do not target pathogens directly. Here we demonstrate that age-dependent decline in adipose tissue lipolysis compromises disease tolerance to SARS-CoV-2 infection. Young adult mice exhibited robust adipocyte lipolysis and 80% survival, whereas old mice showed impaired adipocyte lipolysis and only 20% survival. Genetic repression of adipocyte lipolysis eliminated this age-dependent survival advantage without affecting viral titers, revealing that adipocyte lipolysis is essential for disease tolerance to SARS-CoV-2 in young adults. Impaired adipocyte lipolysis in aged mice was associated with a plasma lipidomic signature that predicts COVID-19 severity and mortality in three independent human cohorts. Mechanistically, adipocyte lipolysis provides free fatty acids (FFA) to support bone marrow emergency myelopoiesis, through CD36- and CPT1-dependent FFA cellular uptake and mitochondrial import, respectively. Bone marrow derived monocytes migrate to the lung via CCL2/CCR2-dependent mechanism where they enforce an immune-metabolic communication network with parenchymal cells to sustain lung structure and function. This circuit is not required to confer protection against influenza infection, revealing pathogen-specific disease tolerance mechanisms. These findings reveal adipose tissue catabolism as a central age-dependent factor responsible for exacerbated COVID-19 mortality in aged populations. One-Sentence Summary: SARS-CoV-2 infection induces adipose tissue lipolysis to release fatty acids that drive myelopoiesis and monocyte production for lung protection and COVID-19 disease tolerance, but this protective circuit declines with age, increasing disease severity in the elderly.